EGFR and neoplasm: Gene sequencing technologies have allowed the identification of driver oncogenic gene alterations in the EGFR gene itself (reviewed in [5]), and/or of genes expressing oncogenic proteins within EGFR’s downstream signalling pathways, especially those that regulate cell survival and proliferation, on which tumour initiation and growth critically depend [6] (examples in Box 1).